Key result
IL-17A neutralization fails to reduce pulmonary or renal vasculitis in experimental autoimmune vasculitis.
Why the study?
The dynamics of the T-cell response within tissues in ANCA-vasculitis were best studied in animal models to analyze lesional T-cell dynamics in experimental autoimmune vasculitis.
Does anti-IL17A treatment ameliorate pulmonary and renal vasculitis in a rat model of experimental autoimmune vasculitis?
Does anti-IL17A treatment ameliorate pulmonary and renal vasculitis in a rat model of experimental autoimmune vasculitis?
Answers are grounded in this paper and cite their sources.
IL-17A neutralization alone is not efficacious in ameliorating pulmonary and renal vasculitis in an experimental autoimmune vasculitis rat model, despite the major participation of Th17 cells.
ANCA-vasculitis (AAV) is a small-vessel vasculitis characterized by the presence of autoantibodies against proteinase-3 (PR3) or myeloperoxidase (MPO). The dynamics of the T-cell response within tissues is studied best in animal models. It was the aim to analyze the lesional T-cell dynamics in the experimental autoimmune vasculitis model. Female Wistar Kyoto-rats were immunized with human MPO emulsified in complete Freund's adjuvant. Control animals received complete Freund's adjuvant without MPO. Selected groups received anti-IL17A treatment. Lesional T-cells from kidneys were assessed by flow cytometry (FACS), realtime polymerase chain reaction (PCR) and EliSpot. All animals immunized with MPO developed signs of vasculitis. At week six, lung damage expressed as petechial bleeding score and renal damage quantified by albuminuria were highest. As analyzed by FACS, the fraction of renal Th17 cells peaked at week six in MPO rats equaling the proportion of Th1 cells. MPO-specific renal Th1 and Th17 cells were detectable by EliSpot at weeks four and six post-immunization in MPO-immunized rats being absent in control rats. Neutralization of IL-17A did not affect the development of humoral and cellular anti-MPO immunity. Likewise, pulmonary and renal vasculitis were not ameliorated. In summary, the dynamics of the lesional T-cell response in the EAV model shows a major participation of MPO-specific Th17 and Th1 cells in renal vasculitis. Simple cytokine neutralization was not efficacious in this disease model so that combined neutralization approaches should be studied further.
No takes yet. Share an insight, caveat, or question.
Zeng et al. (2025) studied Experimental autoimmune vasculitis. Immunization with human MPO and anti-IL17A treatment vs. Complete Freund's adjuvant without MPO was evaluated on Lesional T-cell dynamics and development of pulmonary and renal vasculitis. In an experimental autoimmune vasculitis rat model, neutralization of IL-17A did not ameliorate pulmonary or renal vasculitis despite major participation of MPO-specific Th17 and Th1 cells.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: